Search Results
Nov 26, 2025, 08:32 ET Endora Launches Mission to Send Human Memories to the Moon
videos to written reflections — in space. Endora has partnered with LifeShip, a space time capsule company that sends symbolic human artifacts such as DNA, seeds, and art into space for preservation and future discovery. The memories collected through Endora's Kickstarter will join a LifeShip payload bound
More news about: Endora Technologies
Nov 26, 2025, 06:43 ET Noah Reports Q3 2025 Earnings: Solid Overseas AUA/AUM Growth, Global Booking Center Network Completed, and Full AI Integration Powering New Momentum
innovation, and capitalize on evolving client demand.Leverage AI as a strategic growth driver and fully embed it into the Company's organizational DNA, as the wealth management industry shifts from a human-driven model to an operations-driven one over the next 3–5 years.Activate its four global
More news about: Noah Holdings Limited
Nov 25, 2025, 17:31 ET Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness | DelveInsight
muscles due to their high energy requirements. Mitochondria possess their own genetic material, known as mitochondrial DNA (mtDNA). However, their function is also regulated by nuclear DNA (nDNA), which oversees mtDNA maintenance, mitochondrial protein synthesis, and the formation and activity of respiratory
More news about: DelveInsight Business Research, LLP
Nov 25, 2025, 12:16 ET How AI-Powered Content Automation Generated $3.5M: Black Lotus Ventures Unveils the AI Strategy Behind Viral Product
Senegalese entrepreneur. They ordered the device. And within minutes, they knew they had something. "The product worked, but more importantly, it had the DNA of virality," Hadji observed.Their research revealed that the product belonged to a creator with a substantial following and strong content, but
More news about: Black Lotus Ventures
Nov 25, 2025, 11:30 ET Ollin inaugura sistema pioneiro de testes genéticos
operacional do novo equipamento é mais baixo, o que, aliado à maior velocidade de processamento, de comparação e análise dos milhões de fragmentos de DNA, contribui para democratizar o acesso da população brasileira a esse tipo de teste.68 genomas em 24 horasO
More news about: Ollin
Nov 25, 2025, 09:19 ET G-SHOCK Shrinks Its Most Iconic Watch to Ring Size with the New DWN5600
miniature module and battery. Despite its size, the battery remains replaceable, ensuring long-lasting performance.Staying true to G-SHOCK's DNA, the small but fully functional digital display shows time down to the second, along with calendar, dual time, and stopwatch capabilities. The three
More news about: Casio America, Inc.
Nov 25, 2025, 09:00 ET Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911
CDH17 monoclonal antibody capable of efficient internalization into tumor cells, a novel cleavable linker with high plasma stability, and a proprietary DNA topoisomerase I inhibitor payload, MF-6, specifically designed to overcome the multidrug resistance.Preclinical studies demonstrated that 7MW4911
More news about: Mabwell
Nov 25, 2025, 08:45 ET VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
soon."1. Grolleau E, et al. Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling. Biomolecules. 2023;13(8):1255. https://doi.org/10.3390/biom130812552.
More news about: VolitionRx Limited
Nov 25, 2025, 08:45 ET VolitionRx Limited annonce le premier contrat de vente des tests Nu.Q® Cancer pour la validation clinique en vue d'une utilisation pratique de soins courants
»1. Grolleau E, et al. Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling. Biomolecules. 2023;13(8):1255. https://doi.org/10.3390/biom130812552.
More news about: VolitionRx Limited
Nov 24, 2025, 16:30 ET Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
time to chemotherapy (TTC). In addition, a poster presentation will provide results of an exploratory analysis of early changes in circulating tumor DNA (ctDNA) and correlation to clinical outcomes.Verzenio (abemaciclib; CDK4/6 inhibitor)In a poster presentation, Lilly will
More news about: Eli Lilly and Company
Nov 24, 2025, 13:01 ET Stagwell Partners with Harvard's OpenDP to Guarantee Customer Privacy, Beginning with its Partnership with Palantir for the Future of Marketing
and allows us to maintain trust with shareholders and employees alike," shared John Kahan, Chief AI Officer of Stagwell. "Data privacy is core to our DNA."The Palantir-Stagwell partnership is already seeing client adoption of its early MVP model in the United States.About Harvard University's
More news about: Stagwell Inc.
Nov 24, 2025, 11:58 ET Enquyst Technologies Demonstrates First-in-Class, Chromatography-free Downstream Processing of a Monoclonal Antibody (mAb) with its Patented Isoelectric Point Purification (IPP) Technology Platform and Announces Receipt of a National Institute for Innovation in Manufacturing Biopharmaceutical (NIIMBL) Led Gates Grand Challenge Program Award
able to demonstrate that its IPP technology platform was able to meet or exceed results in the removal of Host Cell Protein (HCP) and Host Cell DNA (HC DNA) impurities, while increasing product yield. With further optimization of its IPP technology platform, Enquyst believes it can surpass these already
More news about: Enquyst Technologies
Nov 24, 2025, 10:38 ET Nokona Celebrates 100th Anniversary with Yearlong Centennial Experiences for Baseball Fans Everywhere
Our commitment to homegrown craftsmanship is a hallmark of Nokona. It is what my great-grandfather, grandfather, and dad instilled in the company's DNA; that won't change ever."There's no doubt that the Nokona Centennial "line-up" has something for everyone. Fast approaching is a never-before-seen
More news about: Nokona
Nov 24, 2025, 10:31 ET Biochips Market worth $21.36 billion by 2030 with 8.8% CAGR | MarketsandMarkets™
maintenance, and customization services supports faster, more efficient research and diagnostics.By type, the market is segmented into DNA Chips, Lab-on-a-Chip, Protein Chips, Tissue Arrays and Cell Arrays. The Lab-on-a-Chip segment is projected to grow at the highest rate during the forecast
More news about: MarketsandMarkets
Nov 24, 2025, 09:00 ET ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed "DNA surgery") with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company's core areas of focus
More news about: ToolGen
Nov 24, 2025, 07:00 ET BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers -- Phase 1/2a clinical trial of GLIX1 expected to commence in Q1 2026 -
More news about: BioLineRx Ltd.
Nov 24, 2025, 07:00 ET Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 23, 2025, 19:00 ET 引正基因與ToolGen聯合宣布達成戰略合作交叉許可協議 加速研發創新基因組編輯療法
業如孟山都（Monsanto）和賽默飛世爾（Thermo Fisher Scientific），展現全球競爭優勢。關於引正基因 GenEditBio 引正基因成立於 2021 年，總部位於中國香港，是一家臨床階段的基因治療初創公司，致力於提供安全、精準、可編程和可根治的體內基因組編輯治療解決方案（簡稱「DNA 手術」），以填補臨床醫治未能滿足的需求。公司的核心研發領域包括新型 Cas 核酸酶基因組編輯器的開發，以及利用脂質納米顆粒（LNP）與工程化蛋白遞送載體（PDV）實現安全和高效的體內遞送。公司在香港、北京和波士頓設有研究實驗室和辦公室。引正基因由頂級生命科學投資者資助，包括啟明創投、方圓資本、晟德、順天醫藥、香港科技園創投基金等。如要更多資訊，請到訪公司網頁
More news about: 引正基因
Nov 21, 2025, 17:33 ET Reiter Affiliated Companies Appoints Grimmway Produce Group President & CEO, Jeff Huckaby to Its Board of Directors
company.""I am humbled by the opportunity to serve on the RAC Board of Directors," shared Huckaby. "Farming is, quite literally, in my DNA and I'm thrilled to be contributing to an industry that has done so much for me. I look forward to supporting the company's continued growth and impact."About
More news about: Reiter Affiliated Companies
Nov 21, 2025, 16:39 ET Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026
Quick-DNA/RNA™ Water Kit: Extracts and purifies total DNA/RNA from large volume water samples, concentrating viruses and low-abundance targets while removing inhibitors, including
More news about: Zymo Research Corp.
Nov 21, 2025, 14:32 ET Everything You Wanted to Know About Your Car, Unlocked: SPARQ Spares Drivers Research, Paperwork and Costs in Seconds
"SPARQ Insights" is a 360-Degree Look at a Car's DNA – from Health to History, Recalls to Repairs – Delivered On-Demand, Putting Control Back in Drivers' HandsNew Features and Demos Available Exclusively to Los Angeles Auto Show Visitors
More news about: SPARQ
Nov 21, 2025, 13:30 ET Researchers Highlight Genetic Factors in Pediatric Brain and Spinal Cord Tumors
Pediatric Brain Tumor Atlas. By studying the DNA and other molecular features of the tumors, they looked for genetic changes present from birth — either inherited from parents or newly occurring in
More news about: Children's Hospital of Philadelphia
Nov 21, 2025, 11:48 ET ALKU and Mass Mentoring Partnership Award $30,000 Scholarship to Boston Student, Esmeilin Gonzalez, Celebrating the Transformative Power of Mentorship
MMP, whose statewide mission is to ensure every young person has access to a supportive mentoring relationship."Mentorship is part of ALKU's DNA," said Andrew Bull, CEO of ALKU. "It's how we grow our people, and it's how we can make an impact beyond our company. Esmeilin Gonzalez's determination
More news about: ALKU
Nov 21, 2025, 10:20 ET Prostate Cancer Drugs Market to Reach USD 28.10 Billion by 2033 | According to DataM Intelligence
radiotherapies. Lutetium-177–PSMA-617 (Pluvicto) saw double-digit growth driven by survival benefits in metastatic disease. With multiple PSMA radiotherapies and DNA-damage repair inhibitors advancing in clinical trials, this segment is expected to expand rapidly through 2033.By Route of Administration (Oral,
More news about: DataM Intelligence 4 Market Research LLP
Nov 21, 2025, 08:00 ET Make-A-Wish Named National Charity Partner for 15th Year in Subaru Share the Love® Event
variety of donated toys, and the event fosters connection between current wish kids and alumni."The act of giving back is woven into Subaru's DNA and the daily mission of our incredible charity partners," said Alan Bethke, Senior Vice President of Marketing, at Subaru of America, Inc. "The Subaru
More news about: MAKE-A-WISH AMERICA